Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q969S9: Variant p.Arg190Gln

Ribosome-releasing factor 2, mitochondrial
Gene: GFM2
Feedback?
Variant information Variant position: help 190 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Glutamine (Q) at position 190 (R190Q, p.Arg190Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In COXPD39. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 190 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 779 The length of the canonical sequence.
Location on the sequence: help AGVEAQTLTVWRQADKHNIP R ICFLNKMDKTGASFKYAVES The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         AGVEAQTLTVWRQADKHNIPRICFLNKMDKTGASFKYAVES

Mouse                         AGVEAQTLTVWRQADKHKIPRICFLNKMDKTGASFNYAVES

Rat                           AGVEAQTLTVWRQADKHKIPRICFLNKMDKTGASFNYAVES

Bovine                        AGVEAQTLTVWRQADKHKVPRICFLNKMDKIGASFNYAVES

Zebrafish                     AGVEAQTMTVWRQAEKHQIPCVCFLNKMDKPAASLRYSLDS

Drosophila                    AGVEAQTVTVWSQADKHKLPRLIFVNKMDRPDADFEKCVSD

Baker's yeast                 AGVEAQTEKVWKQSKSK--PKICFINKMDRMGASFNHTVND

Fission yeast                 AGVEAQTKVVWKQATKRGIPKVIFVNKMDRVGSSLGSTIRS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 779 Ribosome-releasing factor 2, mitochondrial
Domain 68 – 353 tr-type G



Literature citations
Novel GFM2 variants associated with early-onset neurological presentations of mitochondrial disease and impaired expression of OXPHOS subunits.
Glasgow R.I.C.; Thompson K.; Barbosa I.A.; He L.; Alston C.L.; Deshpande C.; Simpson M.A.; Morris A.A.M.; Neu A.; Loebel U.; Hall J.; Prokisch H.; Haack T.B.; Hempel M.; McFarland R.; Taylor R.W.;
Neurogenetics 18:227-235(2017)
Cited for: VARIANTS COXPD39 SER-92 AND GLN-190; INVOLVEMENT IN COXPD39;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.